Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phase separation analysis of recombinant interleukin 2.

C A Bergmann1, B J Landmeier, D R Kaplan

  • 1Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.

Molecular Immunology
|January 1, 1991
PubMed
Summary

Recombinant interleukin 2 (IL-2) molecules show varying amphipathicity due to primary structure changes. These differences, particularly in Cetus and AMGEN IL-2, may impact therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Network approach identifies Pacer as an autophagy protein involved in ALS pathogenesis.

Molecular neurodegeneration·2019
Same author

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.

SpringerPlus·2016
Same author

Axon diameter and axonal transport: In vivo and in vitro effects of androgens.

NeuroImage·2015
Same author

TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival.

Cell death & disease·2014
Same author

Possible target antigens in autoimmune endocrine disease.

Immunology today·2014
Same author

p63 and p73 coordinate p53 function to determine the balance between survival, cell death, and senescence in adult neural precursor cells.

Cell death and differentiation·2014

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Chemistry

Background:

  • Phase separation in Triton X-114 detergent is a method to differentiate secreted from amphipathic proteins.
  • Recombinant interleukin 2 (IL-2) is typically derived from bacterial lysates, not secretion.
  • Understanding IL-2's biochemical properties is crucial for its therapeutic use.

Purpose of the Study:

  • To analyze the amphipathicity of naturally synthesized and recombinant interleukin 2 (IL-2) molecules using Triton X-114 phase separation.
  • To investigate the biochemical differences between various recombinant IL-2 preparations and their native counterpart.
  • To explore the potential impact of structural variations on IL-2's therapeutic efficacy.

Main Methods:

  • Utilizing Triton X-114 detergent phase separation to assess protein partitioning.

Related Experiment Videos

  • Analyzing naturally synthesized and multiple recombinant interleukin 2 (IL-2) variants.
  • Characterizing protein dimerization and multimeric structures through biochemical assays.

    • Main Results:

    • Naturally synthesized IL-2 and R&D Systems recombinant IL-2 partitioned to the aqueous phase, consistent with secreted proteins.
    • Cetus recombinant IL-2 exhibited significant amphipathicity, partitioning into the detergent phase.
    • AMGEN recombinant IL-2 mutein showed intermediate behavior; Cetus and AMGEN IL-2 displayed spontaneous dimerization.
    • Amino acid changes at position 125 distinguish Cetus/AMGEN IL-2 from R&D Systems and native IL-2.

    Conclusions:

    • Subtle primary structure alterations in recombinant interleukin 2 (IL-2) can lead to significant biochemical differences, including amphipathicity and dimerization.
    • These biochemical variations may influence the therapeutic potential and behavior of different recombinant IL-2 formulations.
    • Further investigation into structure-function relationships of IL-2 is warranted for optimizing therapeutic strategies.